The company
Personalis, Inc.
PSNL · Nasdaq
PSNL stood above a rising 150-day average in 39 of the last 52 weekly readings, including each of the last 19 weeks. It is 34.5% above that average now. Diagnostics & Labs: 48% of its 44 stocks in an uptrend (−2 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 19 in a row
- Industry in uptrend
- 48% -2 in 4 wk
- Insider buys, 12 months
- $5.5M
- Insider sales, 12 months
- $16.2M
- Officials’ trades on record
- 3
- Institutions holding
- 154 (+22)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 39 of 52 weeks.
Diagnostics & Labs: About half its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
3 disclosed lines: House 3, Senate 0, executive 0; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Brian J. Mast House: U.S. House ClerkFL18 | sold | $15k–$50k | 19 May 2020filed 4 Jun 2020 |
| Brian J. Mast House: U.S. House ClerkFL18 | sold | $1k–$15k | 22 Apr 2020filed 4 May 2020 |
| Brian J. Mast House: U.S. House ClerkFL18 | bought | $15k–$50k | 14 Feb 2020filed 4 Mar 2020 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Aaron TachibanaCFO AND COO | sold | 2,931at $16.22 | 18 Sep 2026filed 22 Sep 2026 |
| Christopher M. HallChief Executive Officer | sold | 7,459at $16.22 | 18 Sep 2026filed 22 Sep 2026 |
| Richard ChenPresident and CMO | sold | 3,998at $16.22 | 18 Sep 2026filed 22 Sep 2026 |
| Stephen Michael MooreSVP and Chief Legal Officer | sold | 2,068at $16.22 | 18 Sep 2026filed 22 Sep 2026 |
| Richard ChenPresident and CMO | sold | 100,000at $15.15 | 15 Jul 2026filed 15 Jul 2026 |
| Christopher M. HallChief Executive Officer | sold | 100,000at $15.08 | 9 Jul 2026filed 9 Jul 2026 |
| Aaron TachibanaCFO AND COO | sold | 4,982at $14.00 | 29 Jun 2026filed 29 Jun 2026 |
| Aaron TachibanaCFO AND COO | sold | 51,251at $13.18 | 26 Jun 2026filed 26 Jun 2026 |
| Christopher M. HallChief Executive Officer | sold | 100,000at $13.15 | 26 Jun 2026filed 26 Jun 2026 |
| Aaron TachibanaCFO AND COO | sold | 40,000at $12.01 | 4 Jun 2026filed 5 Jun 2026 |
| Aaron TachibanaCFO AND COO | sold | 38,799at $11.58 | 29 May 2026filed 29 May 2026 |
| Christopher M. HallChief Executive Officer | sold | 80,091at $11.02 | 29 May 2026filed 29 May 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Merck & Co., Inc.unchanged · filed 7 Aug 2026 | 14,044,943$188.2M | 00.0% |
| ARK Investment Management LLCadded · filed 14 Aug 2026 | 8,271,339$110.8M | +327,227+4.1% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 7,082,491$94.9M | +1,692,606+31.4% |
| LIGHTSPEED MANAGEMENT COMPANY, L.L.C.reduced · filed 14 Aug 2026 | 6,101,850$81.8M | -2,058,884−25.2% |
| AMERIPRISE FINANCIAL INCreduced · filed 14 Aug 2026 | 6,086,315$81.6M | -1,506,492−19.8% |
| Deep Track Capital, LPadded · filed 14 Aug 2026 | 4,000,000$53.6M | +1,000,000+33.3% |
| Aberdeen Group plcadded · filed 31 Jul 2026 | 3,747,290$50.2M | +258,982+7.4% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 3,010,150$40.3M | +141,687+4.9% |
| Casdin Capital, LLCadded · filed 14 Aug 2026 | 2,550,000$34.2M | +950,000+59.4% |
| KENNEDY CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026 | 2,364,282$31.7M | +180,710+8.3% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
From its SEC filings
Analyst forecasts
No analyst forecasts yet.